191604-91-8

Basic information

• Product Name: 2-METHOXY-5-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE
• Synonyms: 2-METHOXY-5-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE
• CAS NO: 191604-91-8
• Molecular Formula: C₉H₆ClF₃O₃
• Molecular Weight: 254.59
• Mol File: 191604-91-8.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-METHOXY-5-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHOXY-5-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE(191604-91-8)
• EPA Substance Registry System: 2-METHOXY-5-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE(191604-91-8)

Safety Data

• Hazardous Substances Data: 191604-91-8(Hazardous Substances Data)

Upstream product

• 145742-65-0 2-methoxy-5-(trifluoromethoxy)benzaldehyde 
• 710-18-9 1-methoxy-4-(trifluoromethoxy)benzene 
• 191604-88-3 2-methoxy-5-(trifluoromethoxy)benzoic acid 
• 79-37-8 oxalyl dichloride 

Downstream Products

• 1268463-87-1 phenyl 6-methoxy-2-methyl-3-(trifluoromethoxy)benzoate 
• 1268463-88-2 phenyl 6-hydroxy-2-methyl-3-(trifluoromethoxy)benzoate 
• 1268463-89-3 phenyl 6-(tert-butoxycarbonyloxy)-2-methyl-3-(trifluoromethoxy)benzoate 
• 1268463-93-9 phenyl 2-hydroxy-6-methyl-3-nitro-5-(trifluoromethoxy)benzoate 
• 1268463-94-0 phenyl 2-(benzyloxy)-6-methyl-3-nitro-5-(trifluoromethoxy)benzoate 
• 1268463-95-1 phenyl 3-amino-2-(benzyloxy)-6-methyl-5-(trifluoromethoxy)benzoate 
• 1268463-96-2 phenyl 2-(benzyloxy)-3-(bis(tert-butoxycarbonyl)amino)-6-methyl-5-(trifluoromethoxy)benzoate 
• 1268463-90-6 (4aS,11aR,12aS,13S)-3-(benzyloxy)-4a-(tert-butyldimethylsilyloxy)-13-(dimethylamino)-5-hydroxy-4,6-(dioxo-10-(trifluoromethoxy)-4,4a,6,11,11a,12,12a,13-octahydrotetraceno[2,3-d]isoxazol-7-yl)tert-butyl carbonate 
• 1268463-86-0 phenyl 2-methoxy-5-(trifluoromethoxy)benzoate 

Relevant articles and documents

TETRACYCLINE COMPOUNDS

The present invention is directed to a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising th

SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPANES USEFUL FOR THE TREATMENT ALLERGIC DISEASES

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4] diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.